NorthRock Partners’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $825K | Buy |
8,995
+545
| +6% | +$47.7K | 0.01% | 340 |
|
|
2026
Q1 | $720K | Buy |
8,450
+62
| +0.7% | +$5.53K | 0.01% | 359 |
|
|
2025
Q4 | $663K | Sell |
8,388
-6,894
| -45% | -$541K | 0.01% | 328 |
|
|
2025
Q3 | $1.22M | Buy |
15,282
+5,899
| +63% | +$503K | 0.02% | 303 |
|
|
2025
Q2 | $853K | Buy |
9,383
+974
| +12% | +$88.9K | 0.02% | 275 |
|
|
2025
Q1 | $788K | Hold |
8,409
| – | – | 0.03% | 246 |
|
|
2024
Q4 | $764K | Sell |
8,409
-224
| -3% | -$21.4K | 0.02% | 252 |
|
|
2024
Q3 | $896K | Buy |
8,633
+186
| +2% | +$19K | 0.03% | 228 |
|
|
2024
Q2 | $820K | Buy |
8,447
+1,251
| +17% | +$115K | 0.03% | 228 |
|
|
2024
Q1 | $648K | Buy |
7,196
+470
| +7% | +$39.8K | 0.02% | 289 |
|
|
2023
Q4 | $536K | Buy |
+6,726
| New | +$506K | 0.02% | 307 |
|
|
2023
Q3 | – | Sell |
-2,714
| Closed | -$209K | – | 358 |
|
|
2023
Q2 | $209K | Sell |
2,714
-110
| -4% | -$8.52K | 0.02% | 286 |
|
|
2023
Q1 | $212K | Buy |
2,824
+128
| +5% | +$9.52K | 0.02% | 299 |
|
|
2022
Q4 | $212K | Sell |
2,696
-767
| -22% | -$57.5K | 0.02% | 317 |
|
|
2022
Q3 | $243K | Sell |
3,463
-681
| -16% | -$53.4K | 0.03% | 252 |
|
|
2022
Q2 | $332K | Buy |
4,144
+668
| +19% | +$52.2K | 0.03% | 202 |
|
|
2022
Q1 | $264K | Buy |
3,476
+595
| +21% | +$47.1K | 0.02% | 266 |
|
|
2021
Q4 | $246K | Buy |
+2,881
| New | +$225K | 0.02% | 278 |
|
|
2021
Q3 | – | Sell |
-3,893
| Closed | -$317K | – | 285 |
|
|
2021
Q2 | $317K | Buy |
3,893
+327
| +9% | +$26.7K | 0.03% | 188 |
|
|
2021
Q1 | $281K | Buy |
3,566
+27
| +0.8% | +$2.12K | 0.03% | 182 |
|
|
2020
Q4 | $303K | Hold |
3,539
| – | – | 0.03% | 174 |
|
|
2020
Q3 | $273K | Buy |
3,539
+4
| +0.1% | +$305 | 0.03% | 176 |
|
|
2020
Q2 | $259K | Sell |
3,535
-227
| -6% | -$16.1K | 0.03% | 172 |
|
|
2020
Q1 | $250K | Sell |
3,762
-741
| -16% | -$52.3K | 0.04% | 159 |
|
|
2019
Q4 | $310K | Buy |
4,503
+402
| +10% | +$27.4K | 0.03% | 209 |
|
|
2019
Q3 | $301K | Buy |
+4,101
| New | +$298K | 0.04% | 167 |
|
|
2015
Q2 | – | Sell |
-2,888
| Closed | -$200K | – | 49 |
|
|
2015
Q1 | $200K | Hold |
2,888
| – | – | 0.12% | 42 |
|
|
2014
Q4 | $200K | Buy |
+2,888
| New | +$195K | 0.12% | 42 |
|
Other funds holding CL
NorthRock Partners's CL Position: Q2 2026 in Review
NorthRock Partners increased its Colgate-Palmolive (CL) stake by 6.4% in Q2 2026, buying an estimated $47.7K and bringing the position to 8,995 shares worth $825K. The position accounts for 0.01% of the portfolio, ranked #340.
NorthRock Partners first reported a position in CL in Q4 2014 and has held it in 28 quarters since. The position peaked at $1.22M in Q3 2025. 2,023 funds tracked by Wall St. Rank hold CL as of Q2 2026.
- NorthRock Partners held 8,995 shares of Colgate-Palmolive worth $825K as of Q2 2026.
- NorthRock Partners bought 545 Colgate-Palmolive shares in Q2 2026, an estimated $47.7K.
- Colgate-Palmolive made up 0.01% of NorthRock Partners's portfolio in Q2 2026, its #340 holding.
- NorthRock Partners first reported a position in Colgate-Palmolive in Q4 2014 and has held it in 28 quarters since.
- NorthRock Partners's Colgate-Palmolive position peaked at $1.22M in Q3 2025.
- 2,023 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.
Based on NorthRock Partners's 13F filing for Q2 2026, filed 11 Aug 2026.